News & Updates
Filter by Specialty:
Half of patients with EGFRm NSCLC on osimertinib-chemo alive at 4 years in FLAURA2
In the planned final overall survival (OS) analysis of the FLAURA2 trial, first-line (1L) osimertinib plus chemotherapy significantly improved OS compared with osimertinib alone in EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC), supporting osimertinib as the backbone treatment in this setting.
Half of patients with EGFRm NSCLC on osimertinib-chemo alive at 4 years in FLAURA2
29 Sep 2025
Multimodal AI system improves accuracy in identifying interstitial pneumonia
The multimodal artificial intelligence (AI) algorithm that combines computed tomography (CT) and histopathological images improves diagnostic accuracy, consistency, and confidence of pathologists in identifying usual interstitial pneumonia (UIP) in patients with resected lung specimens, reports a study.
Multimodal AI system improves accuracy in identifying interstitial pneumonia
19 Sep 2025
Ultrathin bronchoscopy boosts small airway biopsy potential for diagnosing sarcoidosis
In patients with suspected sarcoidosis, small airway biopsy (SAB) guided by ultrathin bronchoscopy (UTB) shows promise for increasing the detection rate of granulomatous inflammation while minimizing the risk of pneumothorax associated with transbronchial lung biopsy (TBLB).
Ultrathin bronchoscopy boosts small airway biopsy potential for diagnosing sarcoidosis
16 Sep 2025
What’s hot at APS & MCV 2025?
MIMS Doctor brings you extensive coverage of the Asia Pneumonia Summit & MasterClass in Vaccinology 2025, held recently in Taipei, Taiwan. Check out the latest updates on RSV, pneumococcal disease, new vaccines, plus thought-provoking insights from respiratory experts. [READ THE FULL REPORT]
